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Development and optimization of the activated charcoal 
suspension composition based on a mixture design approach
In this study, a new drug product containing activated 
charcoal was designed and developed. The excipient levels 
in the pharmaceutical formulation were optimized using a 
mixture design approach. The adsorption power of the acti-




els and the adsorption power of the formulation. Liquid 
flavour­had­a­critical­impact­on­the­adsorption­power­of­the­




methylcellulose sodium led to a marked decrease in adsorp-
tion­ power.­ The­ obtained­mathematical­ models­ and­ re-
sponse surface allowed selection of the optimal composition 
of­excipients­in­a­final­drug­product.
Keywords: activated charcoal, adsorption power, phena-
zone, experimental design, Quality by Design concept
The­Quality­by­Design­concept­is­an­essential­part­of­the­modern­approach­to­phar-
maceutical quality. It involves designing and developing formulations and manufacturing 
processes­to­ensure­predefined­drug­product­quality­(1).­Due­to­the­current­trend­of­being­
Quality­by­Design­compliant,­the­use­of­experimental­designs­in­pharmaceutical­sciences­
is increasing (2, 3). This strategy can shorten a drug development phase and reduce the 
overall experimental work and costs (4, 5). Furthermore, the use of experimental design 
techniques­enables­better­understanding­of­the­effect­of­material­attributes­and­process­
factors­on­the­final­drug­product­quality­(5).
This paper focuses on the application of experimental design in the development and 
optimization of a new drug product containing activated charcoal. The composition of 
excipients in the formulation was optimized using a mixture design approach according 
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excipient levels in a fi nal drug product. Mixture design was applied to investigate the ef-
fect of varying the ratios of excipients and their interactions on the adsorption power of 
the pharmaceutical dosage form. Due to the fact that the response variable (adsorption 
power) is a function of the properties of diff erent components present in the suspension, 
a mathematical model was constructed to be er understand and predict the output re-
sponse with respect to input variables.
EXPERIMENTAL
All chemicals and solvents were of analytical reagent grade. Phenazone (99%) and 
carboxymethylcellulose sodium salt (high viscosity) were obtained from Sigma-Aldrich 
(USA). Activated charcoal was provided by Pharma Cosmetic (Poland). Sorbitol and HPLC-
-grade acetonitrile were purchased from POCh (Poland). Liquid fl avour (cola aromatic 
base dissolved in triacetin) was purchased from Hoff mann (Poland). Ultrapure water was 
obtained from a Milli-Q water purifi cation system from Millipore (USA).
Preparation of the activated charcoal suspension
In the fi rst stage of the study, the suspension included the following excipients: sorbi-
tol (as a sweetener), liquid fl avour and purifi ed water.
The required amount of sorbitol (according to Table I) was dissolved in purifi ed water. 
The obtained solution was mixed with the activated charcoal in a porcelain mortar and 
then liquid fl avour was added.
In the second stage, a carboxymethylcellulose sodium salt (CMC) was added as a 
suspending agent to the formulation (Table II). Sorbitol was dissolved in purifi ed water. 
The obtained solution was heated in a beaker to a temperature of 35 °C and agitated, the 
required amount of the polymer was dispersed in sorbitol solution. Agitation was con-
tinued without heating to obtain the appropriate consistency of the formulation and then 
0.01 g of liquid fl avour was added. The obtained polymer dispersion was poured onto the 
charcoal powder in a mortar and mixed throughly. In this way, two grams of activated 
charcoal was incorporated into 10 g of the prepared gel formulation.
Adsorption power of activated charcoal suspension
The un-adsorbed phenazone concentration in the fi ltrate was measured using the RP-
-HPLC method. Adsorption power was measured as follows: 1.8 g of activated charcoal 
suspension was weighed into a 100-mL ground-glass stoppered conical fl ask, then 25-mL 
of a freshly prepared phenazone solution (10 mg mL–1) was added. This was shaken thor-
oughly for 15 min at room temperature and fi ltered. One (1.0) mL of the fi ltrate was trans-
ferred into a 25-mL volumetric fl ask and made up to the mark with ultrapure water. The 
obtained phenazone solution (1.0 mL) was transferred into a 25-mL volumetric fl ask and 
diluted with ultrapure water to the mark, mixed and fi ltered through a 0.22-mm membrane 
fi lter prior to being injected into a chromatographic column. Each suspension sample was 
prepared in triplicate. The concentration of phenazone in the investigated fi ltrate was cal-
culated using the calibration curve prepared at nine diff erent concentration levels (in the 
range of 2.54–20.36 mg L–1).
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HPLC method
A reversed phase high performance liquid chromatography method for the determi-
nation of phenazone in fi ltrate was developed with the aid of a HPLC system (Shimadzu, 
Japan) equipped with two LC-20AD solvent delivery pumps, a DGU-20A degasser and a 
diode array detector (SPD-M20A). Chromatographic experiments were performed on a 
GraceSmartTM RP 18 column (150 mm × 4.6 mm, 5 mm, WITKO, USA), combined with a 
SecurityGuardTM precolumn Gemini C18 (length 4 mm, internal diameter 3 mm, Phe-
nomenex, USA). The mobile phase consisted of acetonitrile and water in a volume ratio of 
25:75. All chromatographic experiments were performed in the isocratic mode. The fl ow 
rate was set to 0.5 mL min–1 and the injection volume was 20 mL. Chromatograms were 
recorded at 242 nm and were analyzed by means of the LCSolution so ware.
Experimental design
Mixture design with three factors was used for the optimization of excipient levels in 
the activated charcoal suspension. Mixture design is a special type of response surface 
methodology. In these experiments, the factors are the ingredients of a mixture and, con-
sequently, their levels are not independent (5). The adsorption power of activated charcoal 
suspension was selected as the response variable. In the mixture design approach, the 
response is a function of the proportions of excipients present in a drug product (5, 7). The 
advantage of this methodology is the reduction of the number of experiments needed to 
optimize the response while maintaining the representativeness. The STATISTICA® 10.0 
so ware (StatSo , Tulsa, OK, USA) was used to construct the experimental design as well 
as to analyze the data. Experimental designs for the developed pharmaceutical dosage 
Table I. Design matrix for formulations without carboxymethylcellulose sodium salt
Formulation Sorbitol (%)a Liquid fl avour (%) Purifi ed water (%) Adsorption powerb,c
  1 15.0 5.0 80.0 35.7 ± 0.5
  2   0.0 5.0 95.0 37.9 ± 0.2
  3   7.5 2.5 90.0 39.3 ± 0.9
  4   7.5 0.0 92.5 43.9 ± 0.3
  5   0.0 2.5 97.5 40.9 ± 0.8
  6 15.0 0.0 85.0 43.1 ± 0.1
  7 15.0 2.5 82.5 40.4 ± 0.3
  8 15.0 0.0 85.0 42.0 ± 0.1
  9 15.0 5.0 80.0 35.6 ± 0.7
10   0.0 5.0 95.0 37.3 ± 0.6
11   7.5 2.5 90.0 39.4 ± 0.4
12   0.0 0.0 100.00 45.6 ± 0.3
13   0.0 0.0 100.00 46.1 ± 0.2
14   7.5 5.0 87.5 35.6 ± 0.2
a The solution was mixed with the activated charcoal (2 g) in a porcelain mortar and then liquid fl avour was added.
b Phenazone (g) per 100 g activated charcoal.
c Mean ± SD, n = 3.
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form are given in Tables I and II. The proportion for each excipient is expressed as a frac-
tion of the mixture for each treatment combination; the sum of excipient proportions is 
equal to 100 %. The design resulted in fourteen suspension mixtures.
RESULTS AND DISCUSSION
In the fi rst stage of the study, three suspension excipients: sorbitol, liquid fl avour and 
purifi ed water were considered to be input variables with adsorption power as the re-
sponse. Liquid fl avour was used to improve the taste and smell of the suspension. Sorbitol 
was included in the formulation as a sweetener. Due to the cathartic action of sorbitol, the 
combination of activated charcoal and sorbitol counteracted the constipation produced by 
charcoal alone. As a result, the elimination of toxic substances from the body was much 
easier. The upper limits of the two were found to be 15 % for sorbitol and 5 % for liquid 
fl avour. The imposed restrictions for sorbitol content resulted from the dose recommended 
by the European Pharmacopoeia (8). Higher content of sorbitol in a dosage form may lead to 
gastric irritation and diuretic eff ect.
Fourteen diff erent pharmaceutical formulations were prepared according to the de-
sign matrix described in Table I. The adsorption power of each suspension was deter-
mined by HPLC. Analysis of variance was carried out. Model signifi cance, lack of fi t and 
determination coeffi  cient, which indicate the model fi tness, were evaluated. The multiple 
regression analysis indicated that the polynomial model was signifi cant (p < 0.05) in pre-
dicting the adsorption power of the suspension (Table III). It could explain almost 98 % of 
all variances in the data (R2 = 0.9803) and an insignifi cant lack of fi t was obtained.
Table II. Design matrix for formulations containing carboxymethylcellulose sodium salt (CMC)
Formulation Sorbitol (%) CMC (%) Purifi ed water (%) Adsorption powera,b
  1 15.0 1.0 84.0 33.9 ± 0.1
  2   0.0 0.0 100.00 45.2 ± 0.3
  3   0.0 0.5 99.5 43.6 ± 0.4
  4   7.5 1.0 91.5 34.9 ± 0.4
  5   0.0 1.0 99.0 36.0 ± 0.4
  6 15.0 0.5 84.5 41.0 ± 0.8
  7   7.5 0.0 92.5 44.0 ± 0.1
  8 15.0 1.0 84.0 33.6 ± 0.4
  9   0.0 0.0 100.00 45.4 ± 0.1
10   7.5 0.5 92.0 42.1 ± 0.3
11 15.0 0.0 85.0 43.3 ± 0.7
12   7.5 0.5 92.0 42.3 ± 0.3
13   0.0 1.0 99.0 36.4 ± 0.5
14 15.0 0.0 85.0 44.0 ± 0.1
a Phenazone (g) per 100 g activated charcoal.
b Mean ± SD, n = 3.
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Residual analysis was also carried out in order to verify the assumptions used in 
statistical analysis. Residuals are the diff erence between the observed and predicted val-
ues (calculated from the mathematical model). Normal distribution of the residual values 
was confi rmed using the normal probability plot and the Shapiro-Wilk test.
The adsorption power of activated charcoal suspension is a function of the levels of 
excipients present in the pharmaceutical formulation. The obtained predictive model (for 
formulations without CMC) can be described by the following equation:
 v = 43.60 x + 13.04 y + 45.75 z – 0.76 xy – 6.46 xz – 1.16 yz 
where v is the predicted response (adsorption power), x is the fraction of sorbitol in the 
mixture, y is the fraction of liquid fl avour in the mixture, z is the fraction of purifi ed water 
in the mixture.
The results of this study can be also graphically represented in the so-called triangu-
lar graph. Response surface describes the functional relationship between the adsorption 
power and excipient levels. As can be seen in Fig. 1a, liquid fl avour has a critical impact on 
the adsorption power of the activated charcoal suspension. Formulations containing the 
largest amount of liquid fl avour showed the lowest adsorption power values.
All suspensions, prepared in accordance with the design matrix from Table I, were 
characterized by unsatisfactory consistency. Thus, in the next stage of the study, carboxy-
methylcellulose sodium salt was included as a suspending agent in the pharmaceutical 
formulation in order to achieve appropriate consistency. This polymer increased the vis-
cosity of the formulation and thereby reduced the sedimentation rate of suspended char-
coal particles. Upper limits of the two excipients in the suspension were determined to be 
15 % sorbitol and 1 % carboxymethylcellulose sodium salt. These excipient levels in the 
pharmaceutical formulation were optimized by the mixture design approach based on 
adsorption power measurements. A total of fourteen experiments were performed accord-






square Test F p value
a
Predictive model for formulations without CMC
Model 165.23   5 33.05 79.47  < 0.01
Total error     3.33   8   0.42
Lack of fi t     2.39   3   0.80   4.25     0.08
Pure error     0.94   5   0.19
Total adjusted 168.55 13 12.97
Predictive model for formulations containing CMC
Model 251.17   5 50.23 799.06 < 0.01
Total error     0.50   8   0.06
Lack of fi t     0.15   3   0.05   0.73    0.58
Pure error     0.35   5   0.07
Total adjusted 251.67 13 19.36
a p value less than 0.05 is considered signifi cant.
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ing to the design matrix given in Table II and the average adsorption power values were 
used in data analysis. A polynomial model was generated for the response value using 
multi-linear regression analysis. Adequacy of the developed model and the statistical sig-
nifi cance of the regression coeffi  cients were tested using the analysis of variance. The re-
sults indicated that the model was signifi cant (p < 0.05). It could explain almost 99 % of all 
variances in the data (R2 = 0.9980) and insignifi cant lack of fi t was obtained (Table III). 
Moreover, the assumption of normal distribution of the residuals was also confi rmed by 
the normal probability plot and the Shapiro-Wilk test.
Fig. 1. Mixture response surface contour plot: a) for formulations without carboxymethylcellulose 
sodium salt (CMC), b) containing CMC.
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The adsorption power of activated charcoal suspension (for formulations containing 
CMC) can be described by means of the obtained mathematical model, as follows:
 v = 43.49 x – 2620.55 y + 45.27 z + 2675.36 xy – 1.04 xz – 2690 yz
where v is the predicted response (adsorption power), x is the fraction of sorbitol in the 
mixture, y is the fraction of carboxymethylcellulose sodium salt in the mixture, z is the 
fraction of purifi ed water in the mixture.
Graphical interpretation of the eff ects of excipients on the drug product quality and 
thus searching for the optimal formulation is possible by means of the so-called mixture 
response surface contour plot. As can be seen from Fig. 1b, carboxymethylcellulose sodium 
salt infl uences the adsorption power. A slight increase in the content of this polymer leads 
to a marked decrease of adsorption capacity. However, the use of 0.5 % carboxymethylcel-
lulose sodium salt gives a suspension with satisfactory consistency and adsorption power. 
Due to the adsorption of liquid fl avour onto activated charcoal, it was excluded from the 
formulation. Finally, sorbitol, in an amount of about 12 %, was used as a sweetener to im-
prove the taste of the charcoal suspension. 
According to the results of the present study, it can be stated that 0.5 % carboxymethyl-
cellulose sodium salt and 12–14 % sorbitol might be used in the formulation in order to 
achieve the desirable adsorption power of the fi nal suspension.
The application of this experimental methodology allowed a be er understanding of 
the infl uence of formulation excipients on the critical physicochemical quality a ribute 
(adsorption power) of the activated charcoal suspension. In contrast to the traditional ex-
periment-based and trial-and-error approach, the applied methodology enabled to mini-
mize the number of experiments to be conducted, without a signifi cant loss of information. 
Prognostic mathematical models were generated to describe in detail the interrelations 
between excipients and the critical quality a ribute of the fi nal suspension.
CONCLUSIONS
In this study, a new drug product containing activated charcoal was designed and 
developed using the mixture design approach. It allowed the modeling and analysis of the 
adsorption problem and thus selection of the optimal qualitative and quantitative compo-
sition of excipients, which guarantees the effi  cacy of medical treatment. The results indi-
cated that the mixture design is a useful tool for the activated charcoal drug product de-
sign and development, in accordance with the Quality by Design strategy.
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